Can a male patient with angina who is taking nicorandil safely take tadalafil for erectile dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tadalafil and Nicorandil: Absolute Contraindication

No, tadalafil cannot be taken with nicorandil—this combination is absolutely contraindicated due to the severe risk of life-threatening hypotension. 1

The Critical Contraindication

  • Co-administration of nicorandil with phosphodiesterase-5 inhibitors (including tadalafil) is contraindicated because of a high risk of severe hypotension (Class I, Level C recommendation). 1

  • The FDA label for tadalafil explicitly warns that at least 48 hours must elapse after the last dose of tadalafil before any nitrate or nitrate-like medication (including nicorandil) can be administered, and even then only under close medical supervision with hemodynamic monitoring. 2

  • Nicorandil possesses a nitrate moiety in its chemical structure and functions partly through nitrate-like mechanisms, making it pharmacologically similar to organic nitrates in terms of this dangerous interaction. 3, 4

Why This Combination Is Dangerous

  • Both nicorandil and tadalafil cause vasodilation through complementary mechanisms—nicorandil through both nitrate effects and potassium channel activation, while tadalafil inhibits phosphodiesterase-5. 3

  • When combined, these vasodilatory effects are additive and can produce profound, potentially fatal hypotension that may be refractory to standard resuscitation measures. 1, 2

  • The prolonged half-life of tadalafil (up to 36 hours for clinical effects) means this risk persists long after the dose is taken. 2

Clinical Management for This Patient

  • If the patient requires treatment for erectile dysfunction while taking nicorandil, the nicorandil must be discontinued and an alternative antianginal agent substituted before any PDE-5 inhibitor can be considered. 1

  • Alternative antianginal options that do not contraindicate PDE-5 inhibitors include:

    • Beta-blockers (first-line for angina, Class I recommendation) 5
    • Ivabradine (Class IIa, Level A) 5
    • Amlodipine (Class IIa, Level A) 5
    • Ranolazine (Class IIb, Level C) 5
  • The ESC guidelines explicitly state that phosphodiesterase-5 inhibitors are not contraindicated in patients with heart failure or angina EXCEPT when patients are taking nitrates or nitrate-like drugs. 5

Important Caveat About Timing

  • Even after stopping nicorandil, sufficient washout time must occur before initiating tadalafil—the exact duration depends on nicorandil's elimination kinetics and the patient's renal function. 1

  • Conversely, if a patient on tadalafil develops acute angina requiring nicorandil or nitrates, at minimum 48 hours must pass since the last tadalafil dose, and administration should only occur in a monitored setting where hypotension can be managed. 2

The Bottom Line

This is not a relative contraindication or a "use with caution" scenario—it is an absolute contraindication based on life-threatening drug interaction risk. The patient's angina regimen must be modified to exclude nicorandil before tadalafil can be safely prescribed. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.